Craft

Semler Scientific

Stock Price

$30.8

2024-10-29

Market Capitalization

$215.5 M

2024-10-29

Revenue

$56.3 M

FY, 2024

Semler Scientific Summary

Company Summary

Overview
Semler Scientific is a company that develops, manufactures, and markets products to treat chronic diseases. It offers QuantaFlo, a point-of-care test that measures arterial blood flow in the extremities to aid in diagnosing peripheral arterial disease (PAD).
Type
Public
Status
Active
Founded
2007
HQ
Santa Clara, CA, US | view all locations
Website
http://semlerscientific.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Doug Murphy-Chutorian, Chief Executive Officer

  • Renae Cormier

    Renae Cormier, Chief Financial Officer

  • Jennifer Oliva Herrington

    Jennifer Oliva Herrington, Chief Operating Officer

  • Shane Reid

    Shane Reid, Chief Technology Officer

LocationsView all

1 location detected

  • Santa Clara, CA HQ

    United States

    2344 Walsh Avenue

Semler Scientific Financials

Summary Financials

Revenue (Q3, 2025)
$7.5M
Gross profit (Q3, 2025)
$6.9M
Net income (Q3, 2025)
$16.9M
Cash (Q3, 2025)
$10.2M
EBIT (Q3, 2025)
($5.4M)
Enterprise value
$321.7M

Footer menu